Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2011

Open Access 01-04-2011 | Article

Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China

Authors: G. Li, Q. Wei, Y. Wang, X. Du, Y. Zhao, X. Jiang

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2011

Login to get access

Abstract

The imipenem and meropenem-resistant strains Citrobacter freundii HS70 and Escherichia coli HS510 were isolated from patients in Shanghai, China. By isoelectric focusing, PCR amplification and sequencing, these strains were each found to produce four β-lactamases: TEM-1, KPC-3, SHV-7 and CTX-M-14. A conjugation experiment and plasmid restriction digestion revealed that the bla KPC-3 gene was located on the same plasmid in both isolates. Bidirectional primer walking sequencing showed that the nucleotide sequence surrounding the 3.8 kb bla KPC-3 contained a 671-bp insertion similar to that previously characterized in China. The insertion was located between the promoter and the coding region of the bla KPC-3 gene. Susceptibility testing performed on recombinant strains carrying the bla KPC-3 gene with or without the insertion revealed that minimum inhibitory concentrations of imipenem, meropenem, cefepime, and cefotaxime for E. coli EMU-KPC3 (without insertion) were four times higher than that of E. coli EKPC3 (with insertion). The 671 bp insertion reduced bla KPC-3 expression significantly. Taken together, these results suggest that KPC-3-producing C. freundii and E. coli have begun to emerge in our hospital.
Literature
1.
go back to reference Alba J, Ishii Y, Thomson K, Moland ES, Yamaguchi K (2005) Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother 49:4760–4762PubMedCrossRef Alba J, Ishii Y, Thomson K, Moland ES, Yamaguchi K (2005) Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother 49:4760–4762PubMedCrossRef
2.
go back to reference Clinical and Laboratory Standards Institute (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7–A8, Wayne, PA, USA Clinical and Laboratory Standards Institute (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7–A8, Wayne, PA, USA
3.
go back to reference Cuzon G, Naas T, Demachy MC, Nordmann P (2008) Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 52:796–797PubMedCrossRef Cuzon G, Naas T, Demachy MC, Nordmann P (2008) Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 52:796–797PubMedCrossRef
4.
go back to reference Deshpande LM, Jones RN, Fritsche TR, Sader HS (2006) Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000–2004). Microb Drug Resist 12:223–230PubMedCrossRef Deshpande LM, Jones RN, Fritsche TR, Sader HS (2006) Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000–2004). Microb Drug Resist 12:223–230PubMedCrossRef
5.
go back to reference Dortet L, Radu I, Gautier V, Blot F, Chachaty E, Arlet G (2008) Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. J Antimicrob Chemother 61:455–457PubMedCrossRef Dortet L, Radu I, Gautier V, Blot F, Chachaty E, Arlet G (2008) Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1. J Antimicrob Chemother 61:455–457PubMedCrossRef
6.
go back to reference Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51:3026–3029PubMedCrossRef Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51:3026–3029PubMedCrossRef
7.
go back to reference Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG (2009) Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53:3365–3370PubMedCrossRef Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG (2009) Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53:3365–3370PubMedCrossRef
8.
go back to reference Matthew M, Harris AM (1976) Identification of β-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J Gen Microbiol 94:55–67PubMed Matthew M, Harris AM (1976) Identification of β-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J Gen Microbiol 94:55–67PubMed
9.
go back to reference Naas TP, Nordmann P, Vedel G, Poyart C (2005) Plasmid-mediated carbapenem-hydrolyzing β-Lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 49:4423–4424PubMedCrossRef Naas TP, Nordmann P, Vedel G, Poyart C (2005) Plasmid-mediated carbapenem-hydrolyzing β-Lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 49:4423–4424PubMedCrossRef
10.
go back to reference Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P (2008) Genetic structures at the origin of acquisition of the β-lactamase bla KPC gene. Antimicrob Agents Chemother 52:1257–1263PubMedCrossRef Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P (2008) Genetic structures at the origin of acquisition of the β-lactamase bla KPC gene. Antimicrob Agents Chemother 52:1257–1263PubMedCrossRef
11.
go back to reference Navon-Venezia S, Leavitt AA, Schwaber MJ, Rasheed JK, Srinivasan A, Patel JB, Carmeli Y, Israeli KPC, Kpn Study Group (2009) First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 53:818–820PubMedCrossRef Navon-Venezia S, Leavitt AA, Schwaber MJ, Rasheed JK, Srinivasan A, Patel JB, Carmeli Y, Israeli KPC, Kpn Study Group (2009) First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 53:818–820PubMedCrossRef
12.
go back to reference Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y (2006) Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 50:3098–3101PubMedCrossRef Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y (2006) Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 50:3098–3101PubMedCrossRef
13.
go back to reference Nordann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–236CrossRef Nordann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–236CrossRef
14.
go back to reference Poirel L, Heritier C, Spicq C, Nordmann P (2004) In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 42:3831–3833PubMedCrossRef Poirel L, Heritier C, Spicq C, Nordmann P (2004) In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol 42:3831–3833PubMedCrossRef
15.
go back to reference Queenan AM, Bush K (2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20:440–458PubMedCrossRef Queenan AM, Bush K (2007) Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20:440–458PubMedCrossRef
16.
go back to reference Robledo IE, Moland ES, Aquino EA, Vázquez GJ, Santé MI, Bertrán J, Hanson ND (2007) First report of a KPC-4 and CTX-M producing K. pneumoniae (Kp) isolated from Puerto Rico (PR). Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, Washington, DC, USA. American Society for Microbiology, p 142, Abstract C2-1933 Robledo IE, Moland ES, Aquino EA, Vázquez GJ, Santé MI, Bertrán J, Hanson ND (2007) First report of a KPC-4 and CTX-M producing K. pneumoniae (Kp) isolated from Puerto Rico (PR). Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, Washington, DC, USA. American Society for Microbiology, p 142, Abstract C2-1933
17.
go back to reference Sykes RB, Bonner DP, Bush K, Georgopapadakou NH (1982) Azthreonam (SQ 26, 776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob Agents Chemother 21:85–92PubMed Sykes RB, Bonner DP, Bush K, Georgopapadakou NH (1982) Azthreonam (SQ 26, 776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob Agents Chemother 21:85–92PubMed
18.
go back to reference Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP, Colombian Nosocomial Resistance Study Group (2006) First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 50:2880–2882PubMedCrossRef Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP, Colombian Nosocomial Resistance Study Group (2006) First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother 50:2880–2882PubMedCrossRef
19.
go back to reference Walsh TR (2005) The emergence and implications of metallo-lactamases in Gram-negative bacteria. Clin Microbiol Infect 11(suppl 6):2–9PubMedCrossRef Walsh TR (2005) The emergence and implications of metallo-lactamases in Gram-negative bacteria. Clin Microbiol Infect 11(suppl 6):2–9PubMedCrossRef
20.
go back to reference Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ (2007) Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 51:763–765PubMedCrossRef Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ (2007) Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 51:763–765PubMedCrossRef
21.
go back to reference Wolter DJ, Kurpiel PM, Woodford N, Palepou MF, Goering RV, Hanson ND (2009) Phenotypic and enzymatic comparative analysis between the novel KPC variant, KPC-5, and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemother 53:557–562PubMedCrossRef Wolter DJ, Kurpiel PM, Woodford N, Palepou MF, Goering RV, Hanson ND (2009) Phenotypic and enzymatic comparative analysis between the novel KPC variant, KPC-5, and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemother 53:557–562PubMedCrossRef
22.
go back to reference Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, Painter RE, Suber DF, Shungu D, Silver LL, Inglima K, Kornblum J, Livermore DM (2004) Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 48:4793–4799PubMedCrossRef Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, Painter RE, Suber DF, Shungu D, Silver LL, Inglima K, Kornblum J, Livermore DM (2004) Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 48:4793–4799PubMedCrossRef
23.
go back to reference Woodford N, Zhang J, Warner M, Kaufmann ME, Matos J, MacDonald A, Brudney D, Sompolinsky D, Navon-Venezia S, Livermore DM (2008) Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 62:1261–1264PubMedCrossRef Woodford N, Zhang J, Warner M, Kaufmann ME, Matos J, MacDonald A, Brudney D, Sompolinsky D, Navon-Venezia S, Livermore DM (2008) Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J Antimicrob Chemother 62:1261–1264PubMedCrossRef
24.
go back to reference Yan JJ, Wu SM, Tsai SH, Wu JJ, Su IJ (2000) Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 44:1438–1442PubMedCrossRef Yan JJ, Wu SM, Tsai SH, Wu JJ, Su IJ (2000) Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother 44:1438–1442PubMedCrossRef
25.
go back to reference Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161PubMedCrossRef Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2001) Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161PubMedCrossRef
26.
go back to reference Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2008) Novel carbapenem-hydrolyzing β-lactamase KPC-1 from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 52:809CrossRef Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC (2008) Novel carbapenem-hydrolyzing β-lactamase KPC-1 from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 52:809CrossRef
27.
go back to reference Shen P, Wei Z, Jiang Y, Du X, Ji S, Yu Y, Li L (2009) Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother 53:4333–4338PubMedCrossRef Shen P, Wei Z, Jiang Y, Du X, Ji S, Yu Y, Li L (2009) Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother 53:4333–4338PubMedCrossRef
Metadata
Title
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China
Authors
G. Li
Q. Wei
Y. Wang
X. Du
Y. Zhao
X. Jiang
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2011
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-1124-7

Other articles of this Issue 4/2011

European Journal of Clinical Microbiology & Infectious Diseases 4/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.